-
Macroeconomic Analysis
NewIceland PESTLE Insights – A Macroeconomic Outlook Report
Financial intermediation, real estate and business activities contributed 25.5% to the gross value added (GVA) in 2023, followed by the mining, manufacturing and utilities with 14.6%, and wholesale, retail and hotels with 11.9%. According to GlobalData estimates, the three sectors are expected to grow by 6.2%, 6.4% and 8.0%, respectively, in 2024. Reykjavik contributed 57.6% of Iceland’s GDP and was home to 60.8% of the country’s population as of 2023
-
Macroeconomic Analysis
NewVenezuela PESTLE Insights – A Macroeconomic Outlook Report
Mining, manufacturing and utilities activities contributed 45.9% to the gross value added (GVA) in 2023, followed by wholesale, retail and hotels (24.1%), and construction activities (2.4%), according to GlobalData estimates. According to OPEC, Venezuela has around 303.2 billion barrels of proven crude oil reserves, it produced 716,000 barrels of crude oil per day in 2022.
-
Product Insights
Jiangsu- Cross-border Industrial Solar PV Park
Jiangsu- Cross-border Industrial Solar PV Park is a solar PV project located in Jiangsu, China. The project is currently partially active. Empower your strategies with our Jiangsu- Cross-border Industrial Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Macroeconomic Analysis
Argentina PESTLE Insights – A Macroeconomic Outlook Report
Mining, manufacturing and utilities activities contributed 24.0% to the gross value added (GVA) in 2023, followed by wholesale, retail and hotels activities (21.9%), financial intermediation, real estate and business activities(14.1%). In nominal terms, the three sectors are expected to grow by 61.9%, 61.9% and 61.0%, respectively, in 2024. Four major cities comprised 39.2% of the country’s population in 2023 and the highest concentration of economic activities are in Buenos Aires, the capital of Argentina, according to GlobalData.
-
Macroeconomic Analysis
Brazil PESTLE Insights – A Macroeconomic Outlook Report
Mining, manufacturing and utilities activities contributed 20.8% to the gross value added (GVA) in 2023, followed by financial intermediation, real estate and business activities (16.6%), wholesale, retail and hotels (14.2%). In nominal terms, the three sectors are expected to grow by 5.6%, 6.1% and 5.7%, respectively, in 2024. Sao Paulo, Rio de Janeiro, Belo Horizonte are the major cities of Brazil that contributed 27.3% to the country’s GDP and comprised 19.9% of the country’s population in 2023, according to the...
-
Sector Analysis
NewCzech Republic Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
GlobalData expects Czech Republic’s construction industry to record a subdued growth rate of 0.4% in real terms in 2024, as the country continues to face the effects of elevated inflation, such as the rising cost of both materials and labour, coupled with the continues weakness in the residential sector, thus effecting the overall construction industry. The residential sector, which is the third largest sector is facing a downturn this year, due to rapid fall in the building permits. According to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Volrustomig in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Volrustomig in Hypopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Volrustomig in Hypopharyngeal Cancer Drug Details: MEDI-5752 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Volrustomig in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Volrustomig in Laryngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Volrustomig in Laryngeal Cancer Drug Details: MEDI-5752 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Volrustomig in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Volrustomig in Oropharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Volrustomig in Oropharyngeal Cancer Drug Details: MEDI-5752 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Volrustomig in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Volrustomig in Cervical Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Volrustomig in Cervical Cancer Drug Details: MEDI-5752 is under development for the...